The Pennsylvania Society of Oncology and Hematology represents more than 200 physicians and other health care professionals who care for cancer patients. The Society is a non-profit corporation devoted to the improvement of hematologic and oncologic care of patients.
Membership in the Society is open to physicians, allied health professionals, and institutions with a demonstrated interest and involvement in the care of patients with hematologic and oncologic disorders. It is also open to residents and fellows who are actively enrolled in a full-time residency program in hematology or oncology in Pennsylvania or who are in an appropriate fellowship program. Corporate entities involved in the care and treatment of cancer patients may also become members.
The site provides resources for cancer patients, including a searchable database of Society members for those individuals seeking an oncologist, hematologist, surgical oncologist, or radiation oncologist.
The Pennsylvania Society of Oncology and Hematology is grateful to our Corporate Sponsors, whose donations help us fulfill our mission.
ASCO Addresses New Policies That Threaten Access to Opioids
J. Heine, MD, FACP was recently interviewed by ASCO for their recent article on
new policies that threaten access to opioids. Dr. Heine commented that
“Policymakers who seek to tackle the opioid epidemic should focus primarily on
the main drivers of opioid use disorder – social and environmental factors and
mental illness – as well as treatment for opioid use disorder. While judicious
prescribing is important, patients with cancer and cancer survivors should not
be subjected to arbitrary prescription limits. In 2013 and 2014, the National
Survey on Drug Use and Health found that only 22.1% of people who misused
prescription painkillers got them from a doctor”. Read the full article